Literature DB >> 12182623

Stereoselective synthesis of the beta-anomer of 4'-thionucleosides based on electrophilic glycosidation to 4-thiofuranoid glycals.

Kazuhiro Haraguchi1, Haruhiko Takahashi, Noriaki Shiina, Chikafumi Horii, Yuichi Yoshimura, Ayako Nishikawa, Eiko Sasakura, Kazuo T Nakamura, Hiromichi Tanaka.   

Abstract

Three types of 4-thiofuranoid glycal with different 3,5-O-silyl protecting groups were prepared and their electrophilic glycosidation was investigated. The 3,5-bis-O-(tert-butyldimethylsilyl)-4-thiofuranoid glycal (5) was obtained through mesylation of 2-deoxy-4-thio-D-erythro-pentofuranose (4) and subsequent base-promoted elimination, while thermal elimination of sulfoxide derivatives was suitable for the preparation of 3,5-O-(tetraisopropyldisiloxane-1,3-diyl) (9) and 3,5-O-(di-tert-butylsilylene) (11) 4-thioglycals. The glycosidation reactions of these 4-thioglycals were carried out, in the presence of either PhSeCl or NIS, by using silylated derivatives of uracil, thymine, cytosine, and N(6)-benzoyladenine. Among the three 4-thioglycals, 11 was found to be an excellent glycosyl donor, forming the desired beta-anomer exclusively irrespective of the nucleobase employed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182623     DOI: 10.1021/jo020037x

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Synthesis of 4'-Ethynyl-2'-deoxy-4'-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI.

Authors:  Kazuhiro Haraguchi; Hisashi Shimada; Keiogo Kimura; Genta Akutsu; Hiromichi Tanaka; Hiroshi Abe; Takayuki Hamasaki; Masanori Baba; Elizabeth A Gullen; Ginger E Dutschman; Yung-Chi Cheng; Jan Balzarini
Journal:  ACS Med Chem Lett       Date:  2011-09-08       Impact factor: 4.345

Review 2.  Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues.

Authors:  Mieke Guinan; Caecilie Benckendorff; Mark Smith; Gavin J Miller
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.